Clinical Trial Update: Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant chemotherapy trial using docetaxel and gemcitabine for locally advanced breast cancer is sponsored by the Korean Breast Cancer Study Group…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Korean Breast Cancer Study Group | Conditions: Breast Cancer Stage II, Breast Cancer Stage III | Phase 2 | Status: UNKNOWN